HEALTH.2012.1.2-1
HEALTH.2012.1.2-1
14 projects · €73,332,489 total EU contribution (project-level) · 131 participating organizations · 25 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€73,332,489
Countries active
Participant organizations by country (headquarters in CORDIS).
- Germany (27)
- Netherlands (15)
- Italy (14)
- France (12)
- UK (12)
- Spain (6)
- CH (5)
- BE (4)
- HU (4)
- SE (4)
- AT (3)
- EL (3)
- CY (2)
- CZ (2)
- DK (2)
- FI (2)
- IE (2)
- IL (2)
- NO (2)
- US (2)
- EE (1)
- LT (1)
- MD (1)
- RO (1)
- RS (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- ERASMUS MC3 projects · NL
- Fraunhofer3 projects · DE
- UT2 projects · DE
- BIOMEDICAL RESEARCH FOUNDATION, ACADEMY OF ATHENS2 projects · EL
- INSTITUT GUSTAVE ROUSSY2 projects · FR
- INSERM2 projects · FR
- KLINIKUM DER UNIVERSITAET ZU KOELN2 projects · DE
- LMU MUENCHEN2 projects · DE
- MU2 projects · CZ
- REGIONH2 projects · DK
- UMIL2 projects · IT
- UNIVERSITY COLLEGE LONDON2 projects · —
Projects
Page 1 of 2
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Best EScalation Treatment in Multiple Sclerosis (MS) BEST MS · 305477 | FP7 | €4,880,575 | €6,350,712 | Details |
Next Generation Sequencing platform for targeted Personalized Therapy of Leukemia NGS-PTL · 306242 | FP7 | €5,870,815 | €7,623,352 | Details |
Rational molecular Assessments and Innovative Drug Selection RAIDS · 304810 | FP7 | €5,999,642 | €7,746,906 | Details |
THALAssaemia MOdular Stratification System for personalized therapy of beta-thalassemia THALAMOSS · 306201 | FP7 | €5,020,000 | €6,730,513 | Details |
Improving the lives of Parkinson’s Disease patients while reducing side-effects through tailored deep brain stimulation IMPACT · 305814 | FP7 | €4,980,907 | €7,536,580 | Details |
EPIGENETICS FOR FEMALE PERSONALIZED CANCER CARE EPI-FEM-CARE · 305428 | FP7 | €5,875,387 | €7,633,929 | Details |
Circulating Tumor Cells TheRapeutic APheresis: a novel biotechnology enabling personalized therapy for all cancer patients CTCTRAP · 305341 | FP7 | €6,000,000 | €8,321,935 | Details |
Development of an integrated SPECT/MRI system for enhanced stratification of brain tumour patients prior to patient-specific radio-chemo therapy and early assessment of treatment efficacy INSERT · 305311 | FP7 | €4,600,000 | €5,981,463 | Details |
Glioma Actively Personalized Vaccine Consortium GAPVAC · 305061 | FP7 | €5,970,436 | €7,918,396 | Details |
Personalized diagnostics and treatment of high risk coronary artery disease patients. RISKYCAD · 305739 | FP7 | €5,992,101 | €7,901,915 | Details |